Urea cycle disorders (UCDs) are a group of rare inherited metabolic conditions caused by enzyme deficiency within the hepatic ammonia detoxification pathway. Ornithine transcarbamylase (OTC) deficiency, the most frequently occurring UCD, is an X-linked condition known to yield a vastly heterogeneous phenotype, with variable onset and presentation across the lifespan. Here, we introduce a series of 4 original cases, published as part of this special supplement, that illustrate learnings for the care of heterozygous females with OTC deficiency, including challenges with diagnosis, potential triggers of hyperammonemia, cognitive effects, and approaches to disease management, including peripartum care.
Keywords: IV, intravenous; Late onset; MRI, magnetic resonance imaging; Manifesting heterozygote; OTC, ornithine transcarbamylase; Ornithine transcarbamylase deficiency; Partial onset; UCD, urea cycle disorder; Urea cycle disorder; X-linked.
© 2022 The Author(s).